Severe Hypercapnia Requiring 48-h Whole-Body Hypothermia in an Infant with Acute Bronchiolitis

Michela Librandi1, Serena Scapaticci1, Valentina Chiavaroli2,3

  • 1Department of Pediatrics, University of Chieti-Pescara, 66100 Chieti, Italy.

Insights

Whole-body hypothermia may be a life-saving rescue treatment for infants with severe bronchiolitis and respiratory failure. This approach, while rare, showed significant improvement in a case study with minimal side effects.

Area of Science:

  • Pediatrics
  • Critical Care Medicine
  • Neonatology

Background:

  • Bronchiolitis is a common infant respiratory illness, often managed with supportive care like hydration and oxygen therapy.
  • Severe cases can lead to hypercapnic respiratory failure requiring mechanical ventilation, with limited options for non-responsive patients.
  • Hypothermia is a known neuroprotective strategy and has been explored for other acute conditions.

Observation:

  • A 50-day-old infant with severe respiratory syncytial virus (RSV) bronchiolitis presented with critical hypercapnic respiratory failure.
  • Despite intubation and ventilatory support, the infant's condition deteriorated with increased oxygen demand.
  • Whole-body hypothermia was initiated for 48 hours as a rescue measure.

Findings:

  • The infant showed gradual improvement in respiratory function following whole-body hypothermia.
  • No adverse effects were observed during or after the hypothermia treatment.
  • This intervention potentially reduced carbon dioxide (CO2) production and mitigated tissue damage.

Implications:

  • Whole-body hypothermia may serve as a critical rescue therapy for severe hypercapnic respiratory failure in infants with bronchiolitis.
  • It offers a potential treatment for refractory cases unresponsive to maximal medical and ventilatory support.
  • Further research is warranted to explore the efficacy and safety of hypothermia in this context, considering potential side effects like bradycardia and coagulopathy.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
277
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
186
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
288
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
320
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
732
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
196